Skin Diseases, Infectious Terminated Phase 3 Trials for Linezolid (DB00601)

Also known as: Skin Disease, Infectious

IndicationStatusPhase
DBCOND0032714 (Skin Diseases, Infectious)Terminated3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00865280Study the Safety and Efficacy of PTK 0796 in Patients With Complicated Skin and Skin Structure Infection (CSSSI)Treatment